1MO CAR T cell therapy in patients with primary central nervous system lymphoma: A LOC network study
ESMO Rare Cancers · 2026-03 · 5 · 100142
DOI: 10.1016/j.esmorc.2026.100142 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESMO Rare Cancers, 2026-03. Verfasst von F. Bouille und 18 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bouille, F., Houot, R., Baron, M., Soussain, C., Ursu, R., Boussen, I., Waultier-Rascalou, A., Guffroy, B., Ahle, G., Willems, L., Morschhauser, F., Gastinne, T., Paillassa, J., Moluçon-Chabrot, C., Schmitt, A., Rémy, C., Alcantara, M., Choquet, S., & Houillier, C. (2026). 1MO CAR T cell therapy in patients with primary central nervous system lymphoma: A LOC network study. ESMO Rare Cancers, 5, 100142. https://doi.org/10.1016/j.esmorc.2026.100142
Vancouver
Bouille F, Houot R, Baron M, Soussain C, Ursu R, Boussen I, et al. 1MO CAR T cell therapy in patients with primary central nervous system lymphoma: A LOC network study. ESMO Rare Cancers. 2026;5:100142. doi:10.1016/j.esmorc.2026.100142
BibTeX
@article{Bouille2026,
author = {Bouille, F. and Houot, R. and Baron, M. and Soussain, C. and Ursu, R. and Boussen, I. and Waultier-Rascalou, A. and Guffroy, B. and Ahle, G. and Willems, L. and Morschhauser, F. and Gastinne, T. and Paillassa, J. and Moluçon-Chabrot, C. and Schmitt, A. and Rémy, C. and Alcantara, M. and Choquet, S. and Houillier, C.},
title = {1MO CAR T cell therapy in patients with primary central nervous system lymphoma: A LOC network study},
journal = {ESMO Rare Cancers},
year = {2026},
volume = {5},
pages = {100142},
doi = {10.1016/j.esmorc.2026.100142}
}
EUVIMED